ALT-BB4

· Alteogen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALT-BB4, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer [Phase 1]